We are live on
!
Find out more
BBNX
Beta Bionics
BBNX
BBNX
130 hedge funds and large institutions have $495M invested in Beta Bionics in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 47 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
3.88% more ownership
Funds ownership: 107.26% → 111.13% (+3.9%)
0% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 47
18% less funds holding
Funds holding: 158 → 130 (-28)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
49% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 47
66% less capital invested
Capital invested by funds: $1.44B → $495M (-$944M)
Holders
130
Holders Change
-28
Holders Change %
-17.72%
% of All Funds
1.6%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
24
Increased
47
Reduced
47
Closed
47
Calls
$496K
Puts
–
Net Calls
+$496K
Net Calls Change
+$176K
Top Buyers
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$26.9M |
| 2 |
VPC
Vestal Point Capital
New York
|
+$23.8M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22.7M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$14.1M |
| 5 |
Morgan Stanley
New York
|
+$11.4M |
